Physician

Jamie C Hey, M.D.

According to 2025 Medicare claims, Jamie Hey, M.D. (NPI: 1548271406) practices pulmonary disease in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is PULMONARY ASSOCIATES OF RICHMOND INC (NPI: 1144253444; TIN: 540965764) and primary practice location at 23225-5515.

Hey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,068 traditional Medicare patients, billed 45,691 HCPCS/CPT codes, and received $1,459,580 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,430 prescription claims across 834 beneficiaries totaling $3,787,510 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,641 claims. Open Payments data shows 89 records totaling $1,872. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $216,262 to $1,459,580. Similarly, Part D prescription costs have moved sharply higher in recent years, from $592,104 to $3,787,510. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $47,699 to $103,225.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	909	3,361	$216,262
2016	900	4,733	$245,918
2017	824	4,497	$222,525
2018	1,007	13,175	$477,884
2019	862	13,642	$501,858
2020	770	13,372	$495,526
2021	726	22,745	$815,761
2022	729	22,523	$819,459
2023	841	30,468	$1,043,115
2024	1,068	45,691	$1,459,580

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,542	$592,104
2016	215	1,376	$785,664
2017	207	1,188	$928,015
2018	210	1,272	$1,053,621
2019	232	1,468	$1,264,318
2020	239	1,733	$1,749,639
2021	344	2,130	$1,630,990
2022	404	2,409	$1,961,430
2023	565	3,372	$2,711,186
2024	834	5,430	$3,787,510

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	156	995	$245,792
2016	176	1,112	$231,581
2017	140	895	$36,305
2018	155	1,099	$61,811
2019	228	1,297	$61,692
2020	213	1,165	$57,919
2021	171	922	$57,904
2022	328	1,708	$110,170
2023	430	2,269	$192,632
2024	488	2,641	$207,310

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	543	815	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	192	215	$65
94729	Test to examine how well the lungs exchange gases	176	177	$42
94726	Test to determine lung volumes using sensors	175	176	$41
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	289	328	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	894	35,550	$746,277
Ofev	Nintedanib Esylate	58	1,695	$729,446
Opsumit	Macitentan	32	1,080	$452,719
Uptravi	Selexipag	13	378	$355,663
Dupixent Pen	Dupilumab	41	1,317	$196,696

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	21	110	$83,662
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	97	770	$56,226
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	17	$16,490
E1392	Portable oxygen concentrator, rental	Y	64	451	$15,210
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	21	108	$7,498

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	89	$1,872	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jamie C. Hey, M.D.?

Tedicare shows public-source Medicare data for Jamie C. Hey, M.D. (NPI 1548271406), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jamie C. Hey, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jamie C. Hey, M.D.?

Jamie C. Hey, M.D. is linked to PULMONARY ASSOCIATES OF RICHMOND INC (billing NPI 1144253444) in the available physician profile data.

Does Jamie C. Hey, M.D. have Open Payments data?

Jamie C. Hey, M.D. has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.